Lombard Odier Asset Management (Usa) Corp Bristol Myers Squibb CO Transaction History

Lombard Odier Asset Management (Usa) Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $3.69 Million - $4.42 Million	-60,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.98 Million - $2.31 Million	-37,000 Reduced 38.14%	60,000 $3.74 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $5.74 Million - $6.72 Million	97,000 New	97,000 $5.74 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $1.19 Million - $1.33 Million	-20,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $1.15 Million - $1.31 Million	20,000 New	20,000 $1.24 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.